Delivery of dehydroepiandrosterone to premenopausal women: Effects of micronization and nonoral administration
- 29 February 1996
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 174 (2) , 649-653
- https://doi.org/10.1016/s0002-9378(96)70444-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1993
- Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropinsJournal of Clinical Endocrinology & Metabolism, 1993
- The Effects of Oral Dehydroepiandrosterone on Endocrine-Metabolic Parameters in Postmenopausal Women*Journal of Clinical Endocrinology & Metabolism, 1990
- Persistence of increased bone resorption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late post-menopauseMaturitas, 1989
- Dehydroepiandrosterone Reduces Serum Low Density Lipoprotein Levels and Body Fat but Does not Alter Insulin Sensitivity in Normal Men*Journal of Clinical Endocrinology & Metabolism, 1988
- A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular DiseaseNew England Journal of Medicine, 1986
- Evidence for Adrenocortical Adaptation to Severe Illness*Journal of Clinical Endocrinology & Metabolism, 1985
- Dissociation of Cortisol and Adrenal Androgen Secretion in Patients with Secondary Adrenal InsufficiencyJournal of Clinical Endocrinology & Metabolism, 1979
- Decline of Adrenal Androgen Production as Measured by Radioimmunoassay of Urinary Unconjugated DehydroepiandrosteroneJournal of Clinical Endocrinology & Metabolism, 1978
- Plasma Dehydroepiandrosterone Sulfate in Normal and Pathological ConditionsJournal of Clinical Endocrinology & Metabolism, 1969